Bio-Techne TECH Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's investing cash flow?
- Bio-Techne (TECH) reported investing cash flow of -$5.82M in Q1 2026.
- How has Bio-Techne's investing cash flow changed year-over-year?
- Bio-Techne's investing cash flow increased by 34.4% year-over-year, from -$8.87M to -$5.82M.
- What is the long-term trend for Bio-Techne's investing cash flow?
- Over 4 years (2021 to 2025), Bio-Techne's investing cash flow has grown at a -38.2% compound annual growth rate (CAGR), from -$243.65M to -$35.59M.
- What does investing cash flow mean?
- The net total of cash spent or received from investment activities.
- How do you interpret investing cash flow?
- Negative values are typical for growing companies investing in assets, while positive values may indicate divestment or maturity.
- How does investing cash flow compare across companies?
- Standard metric across all industries to assess capital deployment.